Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue polypeptide specific antigen (TPS) throughout normal pregnancy.

D Kassanos1, D Botsis, D Rizos

  • 1Second Department of Obstetrics and Gynecology, Aretaieion University Hospital, Athens, Greece.

Anticancer Research
|August 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of interferon-stimulated genes in the endometrium, cervix and vagina on Day 15 of pregnancy in cattle.

Theriogenology·2026
Same author

Characterization and miRNA profiling of extracellular vesicles from rabbit oviduct and uterine fluids.

Theriogenology·2025
Same author

Circulating progesterone concentrations and pregnancy outcomes in high-producing lactating dairy cows treated with human chorionic gonadotropin on day 2 of the estrus cycle.

Journal of dairy science·2025
Same author

Response of bovine endometrium to interferon tau in the presence of lipopolysaccharide.

Theriogenology·2024
Same author

Correction: Extracellular vesicles-coupled miRNAs from oviduct and uterus modulate signaling pathways related to lipid metabolism and bovine early embryo development.

Journal of animal science and biotechnology·2024
Same author

Extracellular vesicles-coupled miRNAs from oviduct and uterus modulate signaling pathways related to lipid metabolism and bovine early embryo development.

Journal of animal science and biotechnology·2024

Maternal serum TPS concentrations increase significantly during pregnancy, making this tumor marker reliable only in early pregnancy for monitoring breast cancer patients. Amniotic fluid TPS levels are higher than serum levels.

Area of Science:

  • Reproductive biology
  • Oncology
  • Biochemistry

Background:

  • Tumor markers are crucial for cancer monitoring.
  • Pregnancy significantly alters physiological parameters.
  • Tissue polypeptide-specific antigen (TPS) is a tumor marker.

Purpose of the Study:

  • To measure TPS concentrations in maternal serum (MS) and amniotic fluid (AF) during pregnancy.
  • To assess the utility of TPS as a tumor marker for breast cancer patients during pregnancy.
  • To establish reference ranges for TPS in normal pregnancy.

Main Methods:

  • Informed consent was obtained from 140 participants, including pregnant women across trimesters, women at parturition, and non-pregnant controls.
  • Maternal serum and amniotic fluid samples were collected.

Related Experiment Videos

  • TPS antigen levels were quantified using enzyme immunoassay (BEKI Diagnostics).

    • Main Results:

    • Maternal serum TPS concentrations increased significantly with gestational age (p < 0.0001).
    • Amniotic fluid TPS levels were markedly elevated compared to maternal serum (p < 0.0001) and declined significantly from the second trimester through labor.
    • TPS values during labor varied with delivery mode, being higher in vaginal deliveries than cesarean sections.

    Conclusions:

    • Pregnancy significantly influences maternal serum TPS levels.
    • TPS is a reliable tumor marker for breast cancer patients only during early pregnancy.
    • Further research is needed to understand TPS dynamics throughout pregnancy and its clinical implications.